Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose [corrected] [published erratum appears in J CLIN PHARM THER 2006 Apr;31(2):204].

OBJECTIVES: The present study was conducted to evaluate the safety, tolerability, and pharmacokinetics of TAS-108 after ascending single oral doses and to analyse preliminarily the effect of food on the pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects. METHODS: Twelve he...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Clinical Pharmacy & Therapeutics Vol. 30; no. 5; pp. 459 - 471
Autores principales: Yamaya H, Yoshida K, Kuritani J, Yonezawa J, Tsuda M, Shindo T, Nagayama S, Buzdar AU
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Oct2005
Acceso en línea:Ver este registro en EBSCOhost